Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shushenling Jiaonang (also known as Shushenling Capsules) is a traditional Chinese medicine (TCM) capsule developed and manufactured by Shaanxi Momentum Pharmaceutical. It is formulated from a blend of eleven traditional Chinese herbs, including Lilium brownii (Lily), Curcuma aromatica, calcined Ostrea gigas (Oyster), honey-roasted Glycyrrhiza uralensis (Licorice), vinegar-roasted Cyperus rotundus, Schisandra chinensis, Albizia julibrissin, calcined Dragon Bone, Caulis Polygoni Multiflori (Polygonum multiflorum stem), Salvia miltiorrhiza, and Panax ginseng. Shushenling Jiaonang is approved in China for soothing the liver, regulating qi, relieving depression, and calming the mind. It is primarily indicated for the treatment of neurasthenia, neurosis, and menopausal syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shushenling Jiaonang.